跳至主要内容
临床试验/NCT05175521
NCT05175521
已完成
不适用

Double Blind Randomized Control Trial of Inhaled Isopropyl Alcohol Vapors Versus Inhaled Eucalyptus Scent for the Treatment of Nausea Associated With Acute Migraine

HonorHealth Research Institute2 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2021年11月11日最近更新:

概览

阶段
不适用
状态
已完成
发起方
HonorHealth Research Institute
入组人数
21
试验地点
2
主要终点
Change of Severity of Nausea on Nausea Scale

概览

简要总结

The goal of this study is to compare the efficacy and adverse events of inhaled isopropyl alcohol vapor (IAV) versus placebo (inhaled eucalyptus scent (IES) (1:20 dilution in mineral oil) for treating nausea associated with acute migraine attacks.

详细描述

The main goal of this study is to examine the efficacy of (nausea reduction and time to use of other anti-nausea medications) and side effects of inhaled isopropyl alcohol vapor (IAV) for treating nausea among migraine patients using a double blind randomized control methodology. IAV is being compared inhaled eucalyptus scent (IES) (1:20 dilution in mineral oil) which has not shown benefit for treating nausea or migraine and is therefore considered placebo in this study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients 18 to 65 years old with nausea associated migraines at least twice per month

排除标准

  • Patients \<18 or \>65 years old
  • Patients without a diagnosis of acute migraine

研究组 & 干预措施

Eucalyptus Oil Scent

Placebo Comparator

Eucalyptus oil diluted in mineral oil 1:20

干预措施: Eucalyptus Oil Scent (Other)

Isopropyl Alcohol Vapors

Active Comparator

Isopropyl Alcohol 70%

干预措施: Isopropyl Alcohol Vapors (Other)

结局指标

主要结局

Change of Severity of Nausea on Nausea Scale

时间窗: ½ hour or to the end of treatment

Change in Nausea, modified visual analog score from 0-10 with 10 severe nausea with vomiting, 5 moderate nausea, 1 mild nausea and 0 no nausea.

次要结局

  • Time to Clinically Relevant Nausea Change(½ hour or to the end of treatment)
  • Side effects associated with interventional substance(½ hour, but likely less than 2 hours)
  • Use of anti-nausea medication/Time to use of anti-nausea medication(½ hour or to the end of treatment)

研究者

发起方
HonorHealth Research Institute
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验